The Japanese Biochemical Society/The Molecular Biology Society of Japan

ConBio2017

ConBio2017

Dec 6, 2017 - Dec 9, 2017
Kobe Port Island(Kobe International Conference Center, Kobe Portopia Hotel, Kobe International Exhibition Hall, The Kobe Chamber of Commerce and Industry)

[3P-0981] Creation of novel anticancer inhibitors targeting nicotinamide phosphoribosyltransferase, the rate limiting enzyme of NAD＋ biosynthetic pathway

〇Kiyotaka Katsuragi1, Yasunobu Asawa2, Akira Sato1, Yoko Ogino1, Yusuke Takai1, Atsushi Yoshimori3, Takahiro Oyama4, Hideaki Abe4, Hiroyuki Nakamura2, Seiichi Tanuma1 (1.Fac. of Pharm. Sci., Tokyo Univ. of Sci., 2.Inst. of Innovative Res., Tokyo Tech, 3.Inst. for Theoretical Med., Inc., 4.Hinoki Shinyaku Co., Ltd)

NAD＜SUP＞＋＜/SUP＞ biosynthetic pathway、NAMPT、anticancer drugs

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password